cetalkonium chloride + choline salicylate: clinical use

Prescribing considerations

• Confirm that the lesion is suitable for symptomatic self-care; review symptoms persisting beyond seven days and investigate ulcers lasting over three weeks.
• Consider systemic salicylate exposure after excessive or prolonged use because buccal absorption can occur.
• Review concurrent aspirin, salicylates, anticoagulants and uricosurics.
• Seek obstetric input before use during pregnancy.

Contraindications and cautions

• Children and adolescents under 16 years
• Active peptic ulceration
• Hypersensitivity to salicylates, aspirin, other NSAIDs or product excipients
• The salicylate-related restriction during the third trimester of pregnancy

Monitoring

• Routine laboratory monitoring is not expected for brief topical use as directed.
• Assess for hypersensitivity, bronchospasm or worsening asthma in susceptible people.
• Escalate suspected overuse for assessment of salicylate toxicity.
• Examine persistent, unusual, bleeding or increasingly painful oral lesions.

Clinical pharmacology

Choline salicylate has analgesic and anti-inflammatory activity, principally attributed to inhibition of prostaglandin production. It may be absorbed across buccal mucosa; salicylate is highly protein-bound, metabolised by conjugation and excreted mainly in urine. Cetalkonium chloride provides local bactericidal antiseptic activity.

Formulation and product differences

• Both selected products are clear topical oral gels containing the same active ingredients.
• The original formulation is aniseed flavoured and contains levomenthol and star anise oil; its fragrance components may cause allergic reactions.
• The Cool Mint formulation contains menthol and mint flavour.
• Both formulations contain ethanol and are essentially sodium-free.